Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence

Close monitoring after diagnosis of patients with stage I-III non-small cell lung cancer (NSCLC) may result in fitter patients with lower disease burden at the time of metastatic recurrence or progression compared to patients diagnosed initially as stage IV (de novo). We compared the presentation, t...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Niki Esfahanian, Sze Wah Samuel Chan, Luna J. Zhan, M.Catherine Brown, Khaleeq Khan, Jae Lee, Karmugi Balaratnam, Elizabeth Yan, Jennifer Parker, Miguel Garcia-Pardo, Samir H. Barghout, Lawson Eng, Penelope A. Bradbury, Frances A. Shepherd, Natasha B. Leighl, Adrian G. Sacher, Stephanie Snow, Rosalyn Juergens, Geoffrey Liu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2023-01-01
Saila:	Cancer Treatment and Research Communications
Gaiak:	Metastasis Performance status Disease burden Overall survival Targeted therapies
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2468294223000965
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!